; and (ii) that meet the Food and Drug Administration’s health and safety standards. (B) By 2023, a purchaser of drugs described in this subsection shall only purchase drugs that contain 100 percent of their active pharmaceutical ingredients manufactured in countries— (i) other than the People’s Republic of China